$18.52 -0.09 (%) Meridian Bioscience Inc - NASDAQ

Sep. 17, 2014 | 04:00 PM

Partner Headlines

  1. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROI

    Benzinga | Jul. 14, 2014 | 04:55AM EST
  2. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROE

    Benzinga | May. 5, 2014 | 05:10AM EST
  3. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest EPS

    Benzinga | Apr. 23, 2014 | 04:43AM EST
  4. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest ROA

    Benzinga | Apr. 11, 2014 | 04:41AM EST
  5. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

    Benzinga | Mar. 20, 2014 | 04:29AM EST
  6. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio

    Benzinga | Feb. 13, 2014 | 04:18AM EST
  7. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Jan. 30, 2014 | 04:47AM EST
  8. 13 Stocks Delivering What's Important: Dividend Increases

    GuruFocus | Jan. 27, 2014 | 10:44AM EST
  9. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS

    Benzinga | Jan. 15, 2014 | 04:10AM EST
  10. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROA

    Benzinga | Dec. 30, 2013 | 06:12AM EST
  11. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Dec. 18, 2013 | 04:28AM EST
  12. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Dec. 3, 2013 | 04:26AM EST
  13. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue Estimates

    Benzinga | Nov. 12, 2013 | 06:28AM EST
  14. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

    Benzinga | Nov. 6, 2013 | 05:20AM EST
  15. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio

    Benzinga | Nov. 1, 2013 | 04:26AM EST
  16. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Oct. 21, 2013 | 06:50AM EST
  17. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio

    Benzinga | Oct. 1, 2013 | 03:17AM EST
  18. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

    Benzinga | Sep. 19, 2013 | 04:12AM EST
  19. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Operating Margin

    Benzinga | Sep. 3, 2013 | 05:09AM EST
  20. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Lowest PEG Ratio

    Benzinga | Aug. 19, 2013 | 04:10AM EST
  21. Meridian Life Science® Successfully Manufactures Influenza Challenge Stock for Immune Targeting Systems

    Benzinga | Jul. 30, 2013 | 07:00AM EST
  22. 68 Top Dividend Stocks with Ex-Dividend Date in August 2013

    GuruFocus | Jul. 29, 2013 | 13:22PM EST
  23. Meridian Bioscience Inc. Reports Operating Results (10-Q)

    GuruFocus | Feb. 11, 2013 | 04:07AM EST
  24. Meridian Subsidiary Bioline, Launches ISOLATE II

    Benzinga | Feb. 6, 2013 | 00:10AM EST
  25. 20 Best Yielding Healthcare Growth Stocks and Which to Buy

    GuruFocus | Feb. 2, 2013 | 09:58AM EST
  26. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Revenue Estimates

    Benzinga | Jan. 23, 2013 | 19:05PM EST
  27. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

    Benzinga | Jan. 7, 2013 | 21:02PM EST
  28. Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

    Benzinga | Dec. 19, 2012 | 20:01PM EST
  29. Meridian Bioscience, Inc. (VIVO) Exec VP, CFO Melissa Lueke sells 21,000 Shares

    GuruFocus | Dec. 17, 2012 | 06:09AM EST
  30. Meridian Bioscience, Inc. (VIVO) Executive Chairman William J Motto sells 17,250 Shares

    GuruFocus | Dec. 7, 2012 | 04:40AM EST
  31. UPDATE: Wedbush Securities Downgrades Meridian Bioscience to Underperform, Reiterates $17 PT

    Benzinga | Nov. 28, 2012 | 04:08AM EST
  32. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROE

    Benzinga | Oct. 23, 2012 | 21:29PM EST
  33. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest EPS Estimates

    Benzinga | Oct. 9, 2012 | 20:07PM EST
  34. Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

    Benzinga | Sep. 20, 2012 | 19:48PM EST
  35. 16 Best Dividend Paying Healthcare Stocks

    GuruFocus | Sep. 3, 2012 | 05:35AM EST
  36. Health Care Sector Wrap

    FoxBusiness | Aug. 14, 2012 | 10:46AM EST
  37. 15 of the Best Growing Dividend Achievers

    GuruFocus | Jul. 30, 2012 | 07:02AM EST
  38. Health Care Sector Wrap

    FoxBusiness | Jul. 26, 2012 | 10:43AM EST
  39. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Revenue

    Benzinga | Jul. 10, 2012 | 20:57PM EST
  40. Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

    Benzinga | May. 13, 2012 | 20:20PM EST
  41. Meridian Bioscience Receives FDA Clearance for New Legionella Test

    Benzinga | Feb. 27, 2012 | 06:00AM EST
  42. Top 4 Stocks In The Diagnostic Substances Industry With The Highest Profit Margin

    Benzinga | Feb. 26, 2012 | 21:46PM EST
  43. Meridian Bioscience Inc. Reports Operating Results (10-Q)

    GuruFocus | Feb. 9, 2012 | 04:01AM EST
  44. The Best Yielding Healthcare Dividend Stocks with Fastest Earnings Growth

    GuruFocus | Feb. 2, 2012 | 05:32AM EST
  45. UPDATE: Wedbush Downgrades Meridian Bioscience to Underperform

    Benzinga | Jan. 31, 2012 | 02:52AM EST
  46. Meridian Bioscience Inc. (VIVO) Executive Chairman William J Motto sells 2,000 Shares

    GuruFocus | Jan. 6, 2012 | 03:49AM EST
  47. 10 High Margin Healthcare Dividend Shares

    GuruFocus | Jan. 2, 2012 | 01:20AM EST
  48. Meridian Bioscience Receives FDA Clearance For ImmunoCard C. difficile GDH Test

    Benzinga | Dec. 27, 2011 | 04:16AM EST
  49. Meridian Bioscience Receives FDA Clearance for New Molecular Test: illumigene Group B Streptococcus

    Benzinga | Dec. 12, 2011 | 02:30AM EST
Trading Center